Skip to contentSkip to Braille Studio

Library / Laws / 119th / hr / H.R. 10145 / Introduced in House

H.R. 10145 — Introduced in House

315 words · about 2 min to read

Download .txt All versions Braille ⠃⠗⠋ Print Cite

I 119th CONGRESS 2d Session H. R. 10145 IN THE HOUSE OF REPRESENTATIVES August 24, 2026Ms. Mace introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to direct the Administrator of the Environmental Protection Agency to rely on certain data with respect to a toxicity determination related to a pesticide chemical residue, and for other purposes. 1. Short title This Act may be cited as the Scientific Oversight for Unbiased and Neutral Data in Pesticide Research Act or the SOUND Pesticide Research Act. 2. Multigenerational reproductive toxicity study requirement (a) In general Section 408(b)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 346a(b)(2)) is amended by adding at the end the following: (G) Multigenerational reproductive toxicity study (i) Requirements In establishing, modifying, leaving in effect, or revoking a tolerance or exemption for a pesticide chemical residue, the Administrator shall rely on data that is— (I) comprehensive, as determined by the Administrator; and (II) derived from a multigenerational reproductive toxicity study that includes not fewer than 4 generations of test species. (ii) Review Not later than 180 days after the date of enactment of the Scientific Oversight for Unbiased and Neutral Data Research Act of 2026, the Administrator shall determine whether each determination to establish, modify, revoke, or leave in effect a tolerance or exemption for a pesticide chemical residue under this section is supported by data that meets the requirements under clause (i). . (b) Report Not later than 2 years after the date of enactment of this Act, the Administrator of the Environmental Protection Agency shall submit to Congress a report that identifies each determination that was reviewed, updated, or otherwise changed as a result of the amendments made to section 408(b)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 346a(b)(2)) by this section.